We agree with designating late differentiation; we suggest adding AQP8 to the cluster name (PMID 41115527).
We agree with designating late differentiation; we suggest adding AQP8 to the cluster name (PMID 41115527).
In our dataset (PMID 41115527), LEFTY1 was associated with an early progenitor population. There is no functional reason to designate these cells as colonocytes; we recommend merging this cluster with the progenitor population.
These cells are colonocytes but lack additional distinguishing features. This cluster appears "smeared" over the UMAP, and a fraction may correspond to what we refer to as FABP1+ colonocytes (PMID 41115527).
We agree with re-naming to BEST4+ colonocytes
We agree that there is evidence supporting both TA and absorptive lineage identity. Any cluster designated as TA should express cell cycle genes (e.g., MKI67, CDK1), and these should be included in the rationale for naming. Given that the secretory TA designation is itself under debate, designating this cluster as absorptive TA also warrants careful consideration.
We recommend merging with the general TA cluster. By definition, all TA cells are cycling; separating these populations into two clusters is not functionally meaningful.
We recommend merging with the general TA cluster. By definition, all TA cells are cycling; separating these populations into two clusters is not functionally meaningful.
A better designation is needed based on current understanding of secretory differentiation. There are no data to support that secretory progenitors undergo transit amplification. We suggest relabeling this cluster as "secretory progenitors."
We agree with this designation and recommend re-labeling as "intestinal stem cells" (the canonical term)
We recommend merging both goblet cell subclusters. While studies suggest functional heterogeneity within the goblet cell population, it is unclear whether these subpopulations can be distinguished at the transcript level. We also recommend removing the "secretory" prefix — the accepted term is simply "goblet cells."
We recommend merging both goblet cell subclusters. While studies suggest functional heterogeneity within the goblet cell population, it is unclear whether these subpopulations can be distinguished at the transcript level. We also recommend removing the "secretory" prefix — the accepted term is simply "goblet cells."
We recommend removing the "secretory" prefix. The accepted term is simply "Paneth cells."
We agree with this designation and recommend removing the "secretory" prefix.
Laminin is not typically expressed by colonocytes unless there is underlying pathology. For the annotation phase of a healthy gut atlas, this cluster should not be included as a distinct cell type; it likely represents contamination from IBD or cancer datasets and should be excluded from initial clustering.
Rather than "early," we suggest categorizing by position along the crypt-villus axis. Based on ANPEP expression, we propose the designation "low-to-mid-villus enterocyte." (PMID 28798045)
We recommend removing this cluster. These cells should be excluded during QC prior to publication.
We recommend removing this cluster. Doublets are a technical artifact and should be computationally excluded during quality control rather than retained as a distinct cluster in a published cell atlas.
We recommend removing this cluster from the epithelial atlas. Monocytes are immune cells and do not belong in an annotation framework focused on the intestinal epithelium. They should be represented in a separate immune compartment atlas.
We recommend removing this cluster from the epithelial atlas for the same reason as monocytes. Plasma cells are immune cells and their inclusion here likely reflects contamination of the epithelial fraction. They should be represented within the appropriate immune compartment.
We agree with designating late differentiation; we suggest adding AQP8 to the cluster name (PMID 41115527).
In our dataset (PMID 41115527), LEFTY1 was associated with an early progenitor population. There is no functional reason to designate these cells as colonocytes; we recommend merging this cluster with the progenitor population.
These cells are colonocytes but lack additional distinguishing features. This cluster appears "smeared" over the UMAP, and a fraction may correspond to what we refer to as FABP1+ colonocytes (PMID 41115527).
We agree with re-naming to BEST4+ colonocytes
We agree that there is evidence supporting both TA and absorptive lineage identity. Any cluster designated as TA should express cell cycle genes (e.g., MKI67, CDK1), and these should be included in the rationale for naming. Given that the secretory TA designation is itself under debate, designating this cluster as absorptive TA also warrants careful consideration.
We recommend merging with the general TA cluster. By definition, all TA cells are cycling; separating these populations into two clusters is not functionally meaningful.
We recommend merging with the general TA cluster. By definition, all TA cells are cycling; separating these populations into two clusters is not functionally meaningful.
A better designation is needed based on current understanding of secretory differentiation. There are no data to support that secretory progenitors undergo transit amplification. We suggest relabeling this cluster as "secretory progenitors."
We agree with this designation and recommend re-labeling as "intestinal stem cells" (the canonical term)
We recommend merging both goblet cell subclusters. While studies suggest functional heterogeneity within the goblet cell population, it is unclear whether these subpopulations can be distinguished at the transcript level. We also recommend removing the "secretory" prefix — the accepted term is simply "goblet cells."
We recommend merging both goblet cell subclusters. While studies suggest functional heterogeneity within the goblet cell population, it is unclear whether these subpopulations can be distinguished at the transcript level. We also recommend removing the "secretory" prefix — the accepted term is simply "goblet cells."
We recommend removing the "secretory" prefix. The accepted term is simply "Paneth cells."
We agree with this designation and recommend removing the "secretory" prefix.
Laminin is not typically expressed by colonocytes unless there is underlying pathology. For the annotation phase of a healthy gut atlas, this cluster should not be included as a distinct cell type; it likely represents contamination from IBD or cancer datasets and should be excluded from initial clustering.
Rather than "early," we suggest categorizing by position along the crypt-villus axis. Based on ANPEP expression, we propose the designation "low-to-mid-villus enterocyte." (PMID 28798045)
We recommend removing this cluster. These cells should be excluded during QC prior to publication.
We recommend removing this cluster. Doublets are a technical artifact and should be computationally excluded during quality control rather than retained as a distinct cluster in a published cell atlas.
We recommend removing this cluster from the epithelial atlas. Monocytes are immune cells and do not belong in an annotation framework focused on the intestinal epithelium. They should be represented in a separate immune compartment atlas.
We recommend removing this cluster from the epithelial atlas for the same reason as monocytes. Plasma cells are immune cells and their inclusion here likely reflects contamination of the epithelial fraction. They should be represented within the appropriate immune compartment.